BIOMAT Database Logo BIOMAT Database Logo

[Effect of benzamide derivatives on convulsions induced by the toxic action of oxygen in rats]. 1987

O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ

The reversible MAO-A inhibitor moclobemide (5 mg/kg) was shown to prevent seizures in rats during exposure to toxic oxygen (6 ata). Benzamide derivatives increased the latent period of oxygen seizures and decreased the lethality following hyperbaric oxygenation. The range of anti-MAO activity of moclobemide and clorgyline in the rat brain and heart after toxic oxygenation was studied. It was distinct from those in control animals. Clorgyline was found to be more active in inhibiting MAO during toxic oxygenation in the heart and moclobemide-in the brain. The possibility is shown to prevent oxygen seizures not only with irreversible MAO-A inhibitors (clorgyline), but also with reversible ones (moclobemide).

UI MeSH Term Description Entries
D008297 Male Males
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003010 Clorgyline An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Clorgilin,Chlorgyline,Clorgiline
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
[Effect of 1,4-benzodiazepine derivatives on the toxic action of oxygen under increased pressure].
January 1975, Farmakologiia i toksikologiia,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
Effect of adrenalectomy on convulsions induced by high-pressure oxygen.
July 1979, Canadian journal of physiology and pharmacology,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
INDUCED convulsions prolonged by oxygen.
May 1952, Lancet (London, England),
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
Effect of age on benzodiazepine-induced behavioural convulsions in rats.
January 1983, Nature,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
Effect of some benzamide derivatives on stress-induced behavior and striatum dopamine receptors.
October 1988, Methods and findings in experimental and clinical pharmacology,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
Effect of myo-inositol on convulsions induced by pentylenetetrazole and kainic acid in rats.
January 2007, Bulletin of experimental biology and medicine,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
The effect of intraperitoneal injections of hyperosmotic solutions on convulsions induced by drugs and hyperbaric oxygen.
July 1968, Canadian journal of physiology and pharmacology,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
[EFFECT ON INSULIN CONVULSIONS OF PHENOXYACID DERIVATIVES].
January 1964, Fiziologia normala si patologica,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
Effect of prostaglandin synthetase inhibitors on experimentally induced convulsions in rats.
January 1984, Pharmacology,
O A Gol'dina, and V G Tepliakov, and E A Demurov, and Iu B Koloskov, and V A Zagorevskiĭ
Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey.
April 1973, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!